Correlation Between Verve Therapeutics and Beam Therapeutics

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and Beam Therapeutics, you can compare the effects of market volatilities on Verve Therapeutics and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Beam Therapeutics.

Diversification Opportunities for Verve Therapeutics and Beam Therapeutics

0.57

Correlation Coefficient

Verve Therapeutics  Beam Therapeutics

Very weak diversification

The 3 months correlation between Verve and Beam is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Beam Therapeutics go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Beam Therapeutics

Given the investment horizon of 90 days Verve Therapeutics is expected to generate 1.23 times more return on investment than Beam Therapeutics. However, Verve Therapeutics is 1.23 times more volatile than Beam Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Beam Therapeutics is currently generating about -0.03 per unit of risk. If you would invest  554.00  in Verve Therapeutics on December 28, 2024 and sell it today you would lose (14.00) from holding Verve Therapeutics or give up 2.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Verve Therapeutics  vs.  Beam Therapeutics

Verve Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Verve Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Verve Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Beam Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Beam Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Verve Therapeutics and Beam Therapeutics

The main advantage of trading using opposite Verve Therapeutics and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.

The idea behind Verve Therapeutics and Beam Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.